193 related articles for article (PubMed ID: 20306044)
1. [Neuroendocrine tumors of the stomach. Risk stratification and therapy].
Klöppel G; Scherübl H
Pathologe; 2010 May; 31(3):182-7. PubMed ID: 20306044
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
[TBL] [Abstract][Full Text] [Related]
3. [Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: good prognosis with early detection].
Scherübl H; Faiss S; Jahn HU; Liehr RM; Schwertner C; Steinberg J; Stölzel U; Weinke T; Zimmer T; Klöppel G
Dtsch Med Wochenschr; 2009 Jul; 134(30):1529-35. PubMed ID: 19603370
[TBL] [Abstract][Full Text] [Related]
4. A clinical perspective on gastric neuroendocrine neoplasia.
Lawrence B; Kidd M; Svejda B; Modlin I
Curr Gastroenterol Rep; 2011 Feb; 13(1):101-9. PubMed ID: 21080245
[TBL] [Abstract][Full Text] [Related]
5. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
7. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
8. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
9. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors.
Jiao X; Wang Z; Peng X; Zhang L; Zhou L
Future Oncol; 2020 Oct; 16(28):2197-2207. PubMed ID: 32687408
[No Abstract] [Full Text] [Related]
10. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine colorectal tumors. Surgical and endoscopic treatment].
Hotz HG; Bojarski C; Buhr HJ
Chirurg; 2011 Jul; 82(7):607-11. PubMed ID: 21656304
[TBL] [Abstract][Full Text] [Related]
12. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
[TBL] [Abstract][Full Text] [Related]
13. [Rectal neuroendocrine tumors: endoscopic therapy].
Eick J; Steinberg J; Schwertner C; Ring W; Scherübl H
Chirurg; 2016 Apr; 87(4):288-91. PubMed ID: 26801755
[TBL] [Abstract][Full Text] [Related]
14. Management of Other Gastric and Duodenal Neuroendocrine Tumors.
Laird AM; Libutti SK
Surg Oncol Clin N Am; 2020 Apr; 29(2):253-266. PubMed ID: 32151359
[TBL] [Abstract][Full Text] [Related]
15. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
[TBL] [Abstract][Full Text] [Related]
16. CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
Kim SH; Kim SH; Kim MA; Shin CI; Han JK; Choi BI
Eur Radiol; 2015 Jul; 25(7):1946-57. PubMed ID: 25899412
[TBL] [Abstract][Full Text] [Related]
17. [Neuroendocrine neoplasms of the appendix and colorectum].
Klöppel G; Scherübl H
Pathologe; 2011 Jul; 32(4):314-20. PubMed ID: 21655999
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
[No Abstract] [Full Text] [Related]
19. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
Kim BS; Park YS; Yook JH; Kim BS
Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
[TBL] [Abstract][Full Text] [Related]
20. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
